“Combination of Axitinib and Dasatinib for Anti-Cancer Activities in Two Prostate Cancer Cell Lines”. Bangladesh Journal of Pharmacology, vol. 11, no. 1, Dec. 2015, pp. 130-7, https://doi.org/10.3329/bjp.v11i1.24149.